{
  "id": "9daf2d4b3e682827",
  "title": "BofA Bullish on Ocular Therapeutix ( OCUL ) as AXPAXLI Targets Superiority Label and Faster Regulatory Path in Wet AMD",
  "description": "20251231T170000Z",
  "content": "",
  "source": "finance.yahoo.com",
  "source_url": "https://finance.yahoo.com/news/bofa-bullish-ocular-therapeutix-ocul-162525681.html",
  "published_at": "20251231T170000Z",
  "fetched_at": "2026-01-01T00:26:23.010909+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "regulatory"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://finance.yahoo.com/news/bofa-bullish-ocular-therapeutix-ocul-162525681.html",
    "url_mobile": "",
    "title": "BofA Bullish on Ocular Therapeutix ( OCUL ) as AXPAXLI Targets Superiority Label and Faster Regulatory Path in Wet AMD",
    "seendate": "20251231T170000Z",
    "socialimage": "https://s.yimg.com/ny/api/res/1.2/LUD35wExAJWPPmSuZ8m7fw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/4067a79d31666446af5aa0e314f1d5ad",
    "domain": "finance.yahoo.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}